|
CYLD expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.370990E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.982000E-02 |
| Normal-vs-Stage2 |
7.937200E-01 |
| Normal-vs-Stage3 |
7.558600E-01 |
| Normal-vs-Stage4 |
1.787650E-02 |
| Stage1-vs-Stage2 |
2.643600E-01 |
| Stage1-vs-Stage3 |
4.454200E-01 |
| Stage1-vs-Stage4 |
8.784000E-02 |
| Stage2-vs-Stage3 |
6.502000E-01 |
| Stage2-vs-Stage4 |
1.708120E-02 |
| Stage3-vs-Stage4 |
2.167600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.481800E-02 |
| Normal-vs-AfricanAmerican |
8.028400E-01 |
| Normal-vs-Asian |
9.622400E-01 |
| Caucasian-vs-AfricanAmerican |
3.103400E-01 |
| Caucasian-vs-Asian |
5.219400E-01 |
| AfricanAmerican-vs-Asian |
8.999200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.188300E-02 |
| Normal-vs-Female |
5.637000E-01 |
| Male-vs-Female |
2.671900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.803500E-02 |
| Normal-vs-Extreme_Weight |
7.481500E-03 |
| Normal-vs-Obese |
9.103400E-01 |
| Normal-vs-Extreme_Obese |
1.243800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.664200E-01 |
| Normal_Weight-vs-Obese |
4.752100E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.166800E-01 |
| Extreme_Weight-vs-Obese |
3.257900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.445600E-01 |
| Obese-vs-Extreme_Obese |
1.715620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.835200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.809200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.539750E-02 |
| Normal-vs-Age(81-100Yrs) |
6.397300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.646200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.753600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.082560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.997600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.959630E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.271200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.081800E-02 |
| Normal-VS-Type2 PRCC |
2.299600E-01 |
| Normal-VS-KIRP CIMP |
8.154200E-01 |
| Normal-VS-Unclassified PRCC |
1.710580E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.811600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.949800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.859820E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.808400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.454400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.390800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.798010E-01 |
| Normal-vs-N1 |
3.954000E-01 |
| Normal-vs-N2 |
9.789500E-04 |
| N0-vs-N1 |
7.435800E-01 |
| N0-vs-N2 |
6.630500E-04 |
| N1-vs-N2 |
4.622300E-04 |
|
|
